Hyrimoz (Adalimumab Biosimilar)

Description

Hyrimoz is a biosimilar to Humira containing adalimumab. It is approved for the treatment of the same autoimmune conditions and offers comparable safety and effectiveness. Hyrimoz provides an alternative biologic option as part of modern treatment strategies.